Coma clinical trials

Explore recruiting coma clinical trials.

Recruiting coma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Coma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Dopaminergic disruption induced by traumatic coma: multimodal neuroimaging approaches to characterize dopaminergic pathways abnormalities and biomarkers of recovery using the [18F]LBT-999 radiotracer.

France

Phase II and Phase III (Integrated) EU CTIS Study details

Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients

Netherlands, Ireland, Finland, Germany, Spain

Therapeutic use (Phase IV) EU CTIS Study details

Treating severe brain-injured patients with apomorphine : a behavioural and neuroimaging study

Belgium, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Methylphenidate for Early Awakening in Coma (MEAWAKE)

Austria, Denmark, Germany, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Complexity-enhancing drugs to treat disorders of consciousness (DoC): a ketamine study

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Coma trials by city

Coma in Toronto Coma in Vancouver Coma in Montreal Coma in Calgary Coma in Edmonton Coma in Ottawa Coma in Winnipeg Coma in Quebec City Coma in Hamilton Coma in Kitchener Coma in London Coma in Halifax Coma in New York Coma in Los Angeles Coma in Chicago Coma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease